Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website


Veracyte reported $177.89M in Cash and Equivalent for its fiscal quarter ending in March of 2023.

Cash And Equivalent Change
Agenus AGEN:US USD 164.82M 13.85M
Agilent A:US USD 1.18B 75M
Anika Therapeutics ANIK:US USD 79.74M 6.59M
Arrowhead Research ARWR:US USD 134.96M 67.29M
Bruker BRKR:US USD 597.9M 47.6M
Exact Sciences EXAS:US USD 69.82M 5.49M
Heron Therapeutics HRTX:US USD 27.09M 11.73M
Illumina ILMN:US USD 1.49B 517M
Immunogen IMGN:US USD 201.25M 73.89M
Intrexon XON:US USD 9.74M 4.88M
Karyopharm Therapeutics KPTI:US USD 84.06M 193.9M
Laboratory Of America LH:US USD 393.9M 36.1M
Ligand Pharmaceuticals LGND:US USD 282.66M 237.66M
Myriad Genetics MYGN:US USD 1.7M 1.6M
Rigel Pharmaceuticals RIGL:US USD 40.28M 15.83M
Roche Holding ROG:VX CHF 4.99B 676M
Sangamo BioSciences SGMO:US USD 78.24M 22.2M
Siemens SIE:GR EUR 9.19B 949M
Thermo Fisher Scientific TMO:US USD 3.48B 5.04B
Veracyte VCYT:US USD 177.89M 23.64M
Waters WAT:US USD 486.07M 5.54M